| Comparing hospice and nonhospice patient survival among patients who die within a three-year window SR Connor, B Pyenson, K Fitch, C Spence, K Iwasaki Journal of pain and symptom management 33 (3), 238-246, 2007 | 572 | 2007 |
| A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions AC Villanti, Y Jiang, DB Abrams, BS Pyenson PloS one 8 (8), e71379, 2013 | 261 | 2013 |
| Medicare cost in matched hospice and non-hospice cohorts B Pyenson, S Connor, K Fitch, B Kinzbrunner Journal of pain and symptom management 28 (3), 200-210, 2004 | 174 | 2004 |
| An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost BS Pyenson, MS Sander, Y Jiang, H Kahn, JL Mulshine Health Affairs 31 (4), 770-779, 2012 | 166 | 2012 |
| Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases JR Hoverman, TH Cartwright, DA Patt, JL Espirito, MP Clayton, JS Garey, ... Journal of oncology practice 7 (3S), 52s-59s, 2011 | 118 | 2011 |
| National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs BJ Lahue, B Pyenson, K Iwasaki, HE Blumen, S Forray, JM Rothschild American health & drug benefits 5 (7), 1, 2012 | 114 | 2012 |
| The incidence rate and economic burden of community-acquired pneumonia in a working-age population J Broulette, H Yu, B Pyenson, K Iwasaki, R Sato American health & drug benefits 6 (8), 494, 2013 | 106 | 2013 |
| Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis BS Pyenson, CI Henschke, DF Yankelevitz, R Yip, E Dec American health & drug benefits 7 (5), 272, 2014 | 86 | 2014 |
| Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis K Fitch, K Iwasaki, B Pyenson, C Plauschinat, J Zhang Current medical research and opinion 27 (7), 1425-1429, 2011 | 67 | 2011 |
| Medical claim cost impact of improved diabetes control for medicare and commercially insured patients with type 2 diabetes K Fitch, BS Pyenson, K Iwasaki Journal of Managed Care Pharmacy 19 (8), 609-620, 2013 | 66 | 2013 |
| Consequences of hepatitis C virus (HCV): Costs of a baby boomer epidemic of liver disease B Pyenson, K Fitch, K Iwasaki | 66 | 2009 |
| Medicare cost of colorectal cancer screening: CT colonography vs. optical colonoscopy B Pyenson, PJ Pickhardt, TG Sawhney, M Berrios Abdominal imaging 40, 2966-2976, 2015 | 56 | 2015 |
| Association of stage shift and population mortality among patients with non–small cell lung cancer R Flores, P Patel, N Alpert, B Pyenson, E Taioli JAMA Network Open 4 (12), e2137508-e2137508, 2021 | 52 | 2021 |
| Cost drivers of cancer care: A retrospective analysis of Medicare and commercially insured population claim data 2004-2014 K Fitch, PM Pelizzari, B Pyenson New York: Milliman, 2016 | 50* | 2016 |
| Prevalence, patterns, and cost of care for children with cerebral palsy enrolled in medicaid managed care S Pulgar, S Bains, J Gooch, H Chambers, GH Noritz, E Wright, ... Journal of managed care & specialty pharmacy 25 (7), 817-822, 2019 | 44 | 2019 |
| Medicare cost of osteoporotic fractures. The clinical and cost burden of an important consequence of osteoporosis D Hansen, C Bazell, P Pelizzari, B Pyenson Seattle, WA: Milliman, 2019 | 42 | 2019 |
| Healthcare-associated infections and length of hospital stay in the Medicare population S Dulworth, B Pyenson American Journal of Medical Quality 19 (3), 121-127, 2004 | 42 | 2004 |
| Costs and repeat rates associated with colonoscopy observed in medical claims for commercial and Medicare populations B Pyenson, C Scammell, J Broulette BMC health services research 14, 1-7, 2014 | 36 | 2014 |
| The real-world Medicare costs of Alzheimer disease: considerations for policy and care B Pyenson, TG Sawhney, C Steffens, D Rotter, S Peschin, J Scott, ... Journal of managed care & specialty pharmacy 25 (7), 800-809, 2019 | 35 | 2019 |
| Metabolic syndrome and employer sponsored medical benefits: an actuarial analysis K Fitch, B Pyenson, K Iwasaki Value in health 10, S21-S28, 2007 | 33 | 2007 |
